FDA Inspection 684625 — JICE Pharmaceuticals Company

JICE Pharmaceuticals Company — FEI 1833189

The FDA completed an inspection of JICE Pharmaceuticals Company on October 4, 2010 in Belding, MI. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 6 citations were issued during this inspection. Product area: Veterinary.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 4, 2010
Fiscal Year
2011
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Belding, MI (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
154121 CFR 211.125(b)Examination of issued labels
362321 CFR 211.170(a)Active ingredient retained sample kept
437221 CFR 211.188(b)(8)Labeling control records including specimens or copies
437521 CFR 211.188(b)(5)In-process and laboratory control results
438921 CFR 211.198(a)Procedures to be written and followed